Search - tctmd.com

Displaying 741 - 760 of 2580

Sort: Relevancy | Date

News Conference News TCT 2015

Percutaneous Paravalvular Leak Closure in Failed Surgical Valves Feasible

October 14, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Industry News

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

October 14, 2015

Presentation TCT 2015

TCT 98: Clinical Outcomes at 1-Year With a Repositionable Self-Expanding Transcatheter Aortic Valve

Presenter: Jeffrey J. Popma, Mathew Williams, Ganesh Manoharan

October 13, 2015

Presentation TCT 2015

TCT 82: Single Versus Dual Antiplatelet Therapy in Transcatheter Aortic Valve Replacement A Meta-analysis of Safety and Efficacy Outcomes

Presenter: Lisa K. Jennings, Neal S. Kleiman, Rhanderson Cardoso

October 13, 2015

Presentation TCT 2015

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

Presenter: Michael J. Reardon, Torsten P. Vahl, Henrique Ribeiro

October 13, 2015

Presentation TCT 2015

TCT 97: Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis First Report From the Transcatheter Valve Therapies Registry

Presenter: Jeffrey J. Popma, Mathew Williams

October 13, 2015

Presentation TCT 2015

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Yaling Han

October 13, 2015

Presentation TCT 2015

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

Presenter: Michael J. Reardon, Torsten P. Vahl, Yingqiang Guo

October 13, 2015

Presentation TCT 2015

TCT 96: Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study

Presenter: Jeffrey J. Popma, Mathew Williams, G. Michael Deeb

October 13, 2015

Presentation TCT 2015

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

Presenter: Michael J. Reardon, Torsten P. Vahl, Sung-Han Yoon

October 13, 2015

Presentation TCT 2015

TCT 80: Favorable Effect of Optimal Lipid-Lowering Therapy on Neointimal Tissue Characteristics After Drug-Eluting Stent Implantation Qualitative Optical Coherence Tomographic Analysis

Presenter: Lisa K. Jennings, Neal S. Kleiman, Ji-Yong Jang

October 13, 2015

Presentation TCT 2015

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Gregg W. Stone

October 13, 2015

Presentation TCT 2015

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Melissa Daubert

October 13, 2015

Presentation TCT 2015

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Matthew Sherwood

October 13, 2015

Presentation TCT 2015

TCT 94: Balloon Postdilation of the Self-Expanding CoreValve Transcatheter Aortic Valve Bioprosthesis Procedural Results and In-Hospital Outcomes From 3,532 Patients in the CoreValve US Pivotal and Continued Access Trials

Presenter: Jeffrey J. Popma, Mathew Williams, J. Kevin Harrison

October 13, 2015

Presentation TCT 2015

TCT 78: Efficacy of Long-term Ticagrelor in Stented Patients in PEGASUS-TIMI 54

Presenter: Lisa K. Jennings, Neal S. Kleiman, Marc Bonaca

October 13, 2015

Presentation TCT 2015

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Moritz Seiffert

October 13, 2015

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Advertisement

Percutaneous Paravalvular Leak Closure in Failed Surgical Valves Feasible

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

TCT 98: Clinical Outcomes at 1-Year With a Repositionable Self-Expanding Transcatheter Aortic Valve

TCT 82: Single Versus Dual Antiplatelet Therapy in Transcatheter Aortic Valve Replacement A Meta-analysis of Safety and Efficacy Outcomes

TCT 106: Cardiovascular Magnetic Resonance for the Evaluation of Aortic Regurgitation Following Transcatheter Aortic Valve Replacement Insights on Clinical Outcomes

TCT 97: Transcatheter Aortic Valve Replacement Using the Self-Expanding Bioprosthesis First Report From the Transcatheter Valve Therapies Registry

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

TCT 105: Transcatheter Aortic Valve Implantation Using a New Second-Generation TAVI System J-Valve for High-Risk Patients With Pure Aortic Regurgitation

TCT 96: Self-Expanding TAVR in Patients with Failed Surgical Bioprosthesis: Results from the CoreValve US Expanded Use Study

TCT 104: Clinical Outcomes of Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Stenosis

TCT 80: Favorable Effect of Optimal Lipid-Lowering Therapy on Neointimal Tissue Characteristics After Drug-Eluting Stent Implantation Qualitative Optical Coherence Tomographic Analysis

TCT 79: Efficacy of Cangrelor in Lesions With High-Risk and Low-Risk Angiographic Characteristics The CHAMPION PHOENIX Trial

TCT 95: The Long-term Hemodynamic Performance of Transcatheter Aortic Valve Replacement A Report From the PARTNER I Trial

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

TCT 94: Balloon Postdilation of the Self-Expanding CoreValve Transcatheter Aortic Valve Bioprosthesis Procedural Results and In-Hospital Outcomes From 3,532 Patients in the CoreValve US Pivotal and Continued Access Trials

TCT 78: Efficacy of Long-term Ticagrelor in Stented Patients in PEGASUS-TIMI 54

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content